BCHMF (Bachem Holding AG) Moat Score: 6/10 (As of Jun. 28, 2026)


BCHMF Bachem Holding AG BCHMF
91 GF Score
Price $87.34
GF Value $116.99
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Bachem Holding AG Moat Score?

Bachem Holding AG BCHMF 91 Moat Score is 6 as of Jun. 28, 2026. GuruFocus rates BCHMF with a GF Score™ of 91/100 and a GF Value™ of $116.99 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 1,404 Biotechnology companies, Bachem Holding AG ranks better than 98.93% on this metric.

Bachem Holding AG has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Bachem Holding AG has Narrow Moat: Bachem Holding AG benefits from valuable intellectual property and a strong position in the peptide manufacturing market. It has a solid customer base and some pricing power, but faces competition that prevents a wide moat classification.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Bachem Holding AG might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Bachem Holding AG  (OTCPK:BCHMF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Bachem Holding AG Moat Score Related Terms

BCHMF vs VRTX, REGN, ALNY: Moat Score Comparison

For the Biotechnology subindustry, Bachem Holding AG's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bachem Holding AG Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bachem Holding AG's Moat Score distribution charts can be found below:

* The bar in red indicates where Bachem Holding AG's Moat Score falls into.


BCHMF
91GF Score
Bachem Holding AG BCHMF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Bachem Holding AG (BCHMF) has a Moat Score of 6 as of Jun. 28, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Bachem Holding AG ranks #15 out of 1404 companies in the Biotechnology industry, placing it in the top 1.1%.
Is Bachem Holding AG's Moat Score too high?
Bachem Holding AG's current Moat Score is 6. The Biotechnology industry median Moat Score is 2.00. Bachem Holding AG's value of 6 is 200% above this industry median. Based on the distribution chart, Bachem Holding AG ranks #15 out of 1404 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bachem Holding AG has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bachem Holding AG's Moat Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Bachem Holding AG ranks #15 out of 1404 companies for Moat Score. This places Bachem Holding AG in the top 1% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Bachem Holding AG's value of 6 is 200% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,404 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bachem Holding AG's current Moat Score of 6 is 200% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bachem Holding AG's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bachem Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Bachem Holding AG (BCHMF) is currently considered Modestly Undervalued. The stock's GF Value™ is $116.99, compared to a current price of $87.34 — trading 25.3% below its estimated fair value. The current Moat Score is 6 and 200% above the Biotechnology industry median of 2.00. Bachem Holding AG's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Bachem Holding AG (BCHMF), the current Moat Score is 6 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bachem Holding AG (BCHMF) Overvalued in 2026?

Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued. The current stock price of $87.34 is trading 25.3% below its estimated GF Value™ of $116.99. GuruFocus considers Bachem Holding AG to be Modestly Undervalued.

Key valuation signals for BCHMF:

  • Moat Score: 6
  • GF Value™: $116.99 vs. price of $87.34 (25.3% below fair value)
  • GF Score™: 91/100 with 5 warning signs
  • Industry Position: 200% above the Biotechnology median (#15 of 1404)

No single metric tells the full story. See the BCHMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bachem Holding AG Business Description

Address Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
91GF Score

Get the complete analysis for BCHMF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$87.34
Price
$116.99
GF Value